Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 9652789, 11 pages
http://dx.doi.org/10.1155/2016/9652789
Research Article

miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT

1Department of Otorhinolaryngology, The First Affiliated Hospital of Sun Yat-Sen University, Otorhinolaryngology Institute, Sun Yat-Sen University, Guangzhou, China
2Department of Otorhinolaryngology, The First People’s Hospital of Foshan, Foshan, China
3Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong
4Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Road II, Guangzhou, Guangdong 510080, China

Received 30 August 2016; Accepted 17 November 2016

Academic Editor: David J. Yang

Copyright © 2016 Bin Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Chu and Y. J. Kim, “Laryngeal cancer: diagnosis and preoperative work-up,” Otolaryngologic Clinics of North America, vol. 41, no. 4, pp. 673–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. C. L. Chaffer and R. A. Weinberg, “A perspective on cancer cell metastasis,” Science, vol. 331, no. 6024, pp. 1559–1564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Marioni, R. Marchese-Ragona, G. Cartei, F. Marchese, and A. Staffieri, “Current opinion in diagnosis and treatment of laryngeal carcinoma,” Cancer Treatment Reviews, vol. 32, no. 7, pp. 504–515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Their, “Epithelial–mesenchymal transitions in tumour progression,” Nature Reviews Cancer, vol. 2, no. 6, pp. 442–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-J. Li, G.-H. Zhang, X.-M. Yang et al., “Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma,” Auris Nasus Larynx, vol. 39, no. 2, pp. 186–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zou, H. Yang, F. Chen et al., “Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma,” European Journal of Cancer Prevention, vol. 19, no. 1, pp. 11–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Yang, L. Hui, Y. Wang, H. Yang, and X. Jiang, “Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells,” Tumor Biology, vol. 35, no. 8, pp. 7965–7973, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. V. Iorio and C. M. Croce, “MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review,” EMBO Molecular Medicine, vol. 4, no. 3, pp. 143–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Luo, J. Wu, Z. Li et al., “miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma,” BioMed Research International, vol. 2014, Article ID 374598, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Tian, J. Zhang, J. Ge et al., “MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma,” Medical Oncology, vol. 31, no. 1, article no. 785, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Zhong and X. Xiong, “miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression,” Biological Research, vol. 48, article 60, 2015. View at Publisher · View at Google Scholar
  15. G. Zhang, X. Hou, Y. Li, and M. Zhao, “MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer ishikawa cells,” BMC Cancer, vol. 14, article 440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Tetsu and F. McCormick, “β-catenin regulates expression of cyclin D1 in colon carcinoma cells,” Nature, vol. 398, no. 6726, pp. 422–426, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Mulrane, S. F. McGee, W. M. Gallagher, and D. P. O'Connor, “miRNA dysregulation in breast cancer,” Cancer Research, vol. 73, no. 22, pp. 6554–6562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Cekaite, P. W. Eide, G. E. Lind, R. I. Skotheim, and R. A. Lothe, “MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer,” Oncotarget, vol. 7, no. 6, pp. 6476–6505, 2016. View at Publisher · View at Google Scholar
  19. J.-W. Yan, J.-S. Lin, and X.-X. He, “The emerging role of miR-375 in cancer,” International Journal of Cancer, vol. 135, no. 5, pp. 1011–1018, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Hagman, B. S. Haflidadóttir, J. A. Ceder et al., “MiR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients,” British Journal of Cancer, vol. 108, no. 8, pp. 1668–1676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Gandellini, M. Folini, N. Longoni et al., “miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cε,” Cancer Research, vol. 69, no. 6, pp. 2287–2295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Berber, I. Yilmaz, G. Narli, A. Haholu, Z. Kucukodaci, and D. Demirel, “MiR-205 and miR-200c: predictive micro RNAs for lymph node metastasis in triple negative breast cancer,” Journal of Breast Cancer, vol. 17, no. 2, pp. 143–148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Z. Yin, F. Li, L. Zhang, X. P. Ren, N. Zhang, and J. F. Wen, “Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 7, pp. 1027–1032, 2014. View at Google Scholar
  24. S. Liu, M. T. Tetzlaff, A. Liu, B. Liegl-Atzwanger, J. Guo, and X. Xu, “Loss of microRNA-205 expression is associated with melanoma progression,” Laboratory Investigation, vol. 92, no. 7, pp. 1084–1096, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Zhang, X. Hou, Y. Li, and M. Zhao, “MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer ishikawa cells,” BMC Cancer, vol. 14, no. 1, article no. 440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Xie, Y. Zhao, S. Caramuta, C. Larsson, and W.-O. Lui, “miR-205 expression promotes cell proliferation and migration of human cervical cancer cells,” PLoS ONE, vol. 7, no. 10, Article ID e46990, 2012. View at Publisher · View at Google Scholar
  27. K. Matsushima, H. Isomoto, N. Yamaguchi et al., “MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells,” Journal of Translational Medicine, vol. 9, article 30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-L. Ku, W.-H. Kim, J.-H. Lee et al., “Establishment and characterization of human laryngeal squamous cell carcinoma cell lines,” Laryngoscope, vol. 109, no. 6, pp. 976–982, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Xu, M. Guo, X. Liu, C. Wang, and Y. Liu, “Inferring the soybean (Glycine max) microrna functional network based on target gene network,” Bioinformatics, vol. 30, no. 1, pp. 94–103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Schouten, S. A. Fratantoni, C. J. Hubens et al., “MicroRNA-124 and -137 cooperativity controls caspase-3 activity through BCL2L13 in hippocampal neural stem cells,” Scientific Reports, vol. 5, Article ID 12448, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Tsukerman, R. Yamin, E. Seidel et al., “MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b,” Oncotarget, vol. 5, no. 23, pp. 12141–12150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Singh, J. M. Alex, and F. Bast, “Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer,” Medical Oncology, vol. 31, no. 1, article 805, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Cai, L. Fang, Y. Huang et al., “miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer,” Cancer Research, vol. 73, no. 17, pp. 5402–5415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Lei, Y. Huang, and W. Gong, “miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN,” Oncology Reports, vol. 30, no. 6, pp. 2897–2902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. J. Lim, P. Crowe, and J.-L. Yang, “Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 4, pp. 671–689, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. Q.-Y. Zhao, F. Ju, Z.-H. Wang, X.-Z. Ma, and H. Zhao, “ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 9, pp. 15498–15505, 2015. View at Google Scholar · View at Scopus
  37. C. Yu, Y. Liu, H. Tan et al., “Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial–mesenchymal transition,” Cancer Letters, vol. 343, no. 2, pp. 258–267, 2014. View at Publisher · View at Google Scholar · View at Scopus